Next Article in Journal
A Triple Staining Method for Accurate Cell Cycle Analysis Using Multiparameter Flow Cytometry
Previous Article in Journal
Fluorescent Probes for Nucleic Acid Visualization in Fixed and Live Cells
Article Menu

Export Article

Open AccessArticle
Molecules 2013, 18(12), 15398-15411;

Bortezomib Congeners Induce Apoptosis of Hepatocellular Carcinoma via CIP2A Inhibition

Department of Chemistry, National Central University, Taoyuan 32001, Taiwan
Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 11221, Taiwan
Department of Medical Research, National Taiwan University Hospital, Taipei 10048, Taiwan
National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei 10002, Taiwan
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 25 August 2013 / Revised: 20 November 2013 / Accepted: 28 November 2013 / Published: 11 December 2013
Full-Text   |   PDF [1074 KB, uploaded 18 June 2014]   |  


CIP2A is an oncoprotein that upregulates p-Akt and promotes cancer cell proliferation and survival. The proteasome inhibitor bortezomib has been shown to reduce CIP2A and lead to cell apoptosis. Here; we modified the functional group of bortezomib to generate a series of novel compounds and conducted a structure–activity relationship (SAR) study. The results showed that compound 1 was able to repress CIP2A expression and cell apoptosis in the same manner as bortezomib, but with less potency in inhibition of proteasome activity. This finding provides a new direction for the design of CIP2A inhibitors. View Full-Text
Keywords: CIP2A; bortezomib; apoptosis CIP2A; bortezomib; apoptosis

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Hou, D.-R.; Huang, A.-C.; Shiau, C.-W.; Wang, C.-Y.; Yu, H.-C.; Chen, K.-F. Bortezomib Congeners Induce Apoptosis of Hepatocellular Carcinoma via CIP2A Inhibition. Molecules 2013, 18, 15398-15411.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top